JO
VYGR icon

John Overdeck’s Voyager Therapeutics VYGR Stock Holding History

John Overdeck’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.32M Buy
948,517
+332,857
+54% +$1.26M ﹤0.01% 2539
2026
Q1 		$2.38M Buy
615,660
+392,947
+176% +$1.55M ﹤0.01% 2621
2025
Q4 		$875K Buy
222,713
+81,998
+58% +$363K ﹤0.01% 3014
2025
Q3 		$657K Buy
+140,715
New +$509K ﹤0.01% 2852
2024
Q2 		– Sell
-22,112
Closed -$206K – 3354
2024
Q1 		$206K Buy
22,112
+12
+0.1% +$101 ﹤0.01% 2708
2023
Q4 		$187K Sell
22,100
-11,500
-34% -$83.4K ﹤0.01% 2852
2023
Q3 		$260K Sell
33,600
-23,795
-41% -$217K ﹤0.01% 2542
2023
Q2 		$657K Buy
57,395
+31,395
+121% +$325K ﹤0.01% 2192
2023
Q1 		$200K Buy
+26,000
New +$207K ﹤0.01% 2553
2022
Q3 		– Sell
-33,427
Closed -$198K – 2851
2022
Q2 		$198K Sell
33,427
-63,030
-65% -$426K ﹤0.01% 2165
2022
Q1 		$735K Buy
+96,457
New +$430K ﹤0.01% 1836
2021
Q3 		– Sell
-13,459
Closed -$56K – 4763
2021
Q2 		$56K Sell
13,459
-313,535
-96% -$1.42M ﹤0.01% 3943
2021
Q1 		$1.54M Buy
+326,994
New +$2.23M ﹤0.01% 1914
2020
Q1 		– Sell
-71,897
Closed -$1M – 3885
2019
Q4 		$1M Sell
71,897
-4,033
-5% -$58.6K ﹤0.01% 2184
2019
Q3 		$1.31M Buy
75,930
+28,339
+60% +$595K ﹤0.01% 1758
2019
Q2 		$1.29M Buy
+47,591
New +$1.09M ﹤0.01% 1743
2019
Q1 		– Sell
-140,536
Closed -$1.32M – 3507
2018
Q4 		$1.32M Buy
140,536
+55,055
+64% +$706K 0.01% 1472
2018
Q3 		$1.62M Sell
85,481
-85,336
-50% -$1.64M ﹤0.01% 1627
2018
Q2 		$3.34M Buy
170,817
+153,717
+899% +$3.04M 0.01% 1275
2018
Q1 		$321K Buy
+17,100
New +$370K ﹤0.01% 2742

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

John Overdeck's VYGR Position: Q2 2026 in Review

John Overdeck increased its Voyager Therapeutics (VYGR) stake by 54% in Q2 2026, buying an estimated $1.26M and bringing the position to 948,517 shares worth $3.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2539.

John Overdeck first reported a position in VYGR in Q1 2018 and has held it in 20 quarters since. The position peaked at $3.34M in Q2 2018. 135 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • John Overdeck held 948,517 shares of Voyager Therapeutics worth $3.32M as of Q2 2026.
  • John Overdeck bought 332,857 Voyager Therapeutics shares in Q2 2026, an estimated $1.26M.
  • Voyager Therapeutics made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2539 holding.
  • John Overdeck first reported a position in Voyager Therapeutics in Q1 2018 and has held it in 20 quarters since.
  • John Overdeck's Voyager Therapeutics position peaked at $3.34M in Q2 2018.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.